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Abstract
Background: Human Coronaviruses (HCoV) are a common cause of respiratory illnesses and are responsible for
considerable morbidity and hospitalization across all age groups especially in individuals with compromised
immunity. There are six known species of HCoV: HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, MERS-CoV
and SARS-HCoV. Although studies have shown evidence of global distribution of HCoVs, there is limited information
on their presence and distribution in Kenya.
Methods: HCoV strains that circulated in Kenya were retrospectively diagnosed and molecularly characterized. A total
of 417 nasopharyngeal specimens obtained between January 2009 and December 2012 from around Kenya were
analyzed by a real time RT-PCR using HCoV-specific primers. HCoV-positive specimens were subsequently inoculated
onto monolayers of LL-CMK2 cells. The isolated viruses were characterized by RT-PCR amplification and sequencing of
the partial polymerase (pol) gene.
Results: The prevalence of HCoV infection was as follows: out of the 417 specimens, 35 (8.4 %) were positive for HCoV,
comprising 10 (2.4 %) HCoV-NL63, 12 (2.9 %) HCoV-OC43, 9 (2.1 %) HCoV-HKU1, and 4 (1 %) HCoV-229E. The Kenyan
HCoV strains displayed high sequence homology to the prototypes and contemporaneous strains. Evolution analysis
showed that the Kenyan HCoV-OC43 and HCoV-NL63 isolates were under purifying selection. Phylogenetic
evolutionary analyses confirmed the identities of three HCoV-HKU1, five HCoV-NL63, eight HCoV-OC43 and three
HCoV-229E.
Conclusions: There were yearly variations in the prevalence and circulation patterns of individual HCoVs in Kenya. This
paper reports on the first molecular characterization of human Coronaviruses in Kenya, which play an important role in
causing acute respiratory infections among children.
Keywords: Molecular characterization, Human coronaviruses, Prevalence, Kenya, HCOV-NL63, HCoV-OC43, HCoV-229E,
HCoV-HKU1
Background
Coronaviruses are enveloped viruses with a linear, non-
segmented, positive-sense, single-stranded RNA genome
of about 27–32 kb [1]. They are round and sometimes
pleiomorphic virions of approximately 80-120 nm in
diameter. Their genome is the largest of all RNA vi-
ruses [2, 3]. Coronaviruses share features of genome
organization and replication strategy, but have different
virion morphology and genome lengths. The 20 kb poly-
merase (pol) gene, which covers the 5′ two-thirds of the
coronavirus genome, contains two large open reading
frames (ORFs), ORF 1a and ORF 1b [1]. ORF 1b hosts the
most highly conserved genomic sequences, encoding con-
served functions such as polymerase and helicase activity
[4]. These functions combined with similarities in replica-
tion and expression strategies, exhibit an evolutionary link
among coronaviruses, arteriviruses, and toroviruses, thus
forming the rationale for placing these viruses in the order
Nidovirales [1]. Therefore, the highly conserved structure
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and function of viral polymerases make the pol a logical
region for making phylogenetic comparisons.
Coronaviruses cause various diseases in different hosts,
such as respiratory tract infections, gastroenteritis, hepa-
titis, and encephalomyelitis in birds and mammals [5].
Coronaviruses are classified into four distinct phylogenetic
groups. Whereas alphacoronaviruses, betacoronaviruses
and gammacoronaviruses infect mammals, deltacorona-
viruses infect avian species [6]. All known human corona-
viruses (HCoV) belong to the alphacoronavirus and
betacoronaviruses. HCoV cause 30 % of common colds as
well as severe infections in infants, children, and immuno-
compromised persons and the elderly [7]. HCoVs have a
worldwide circulation, with reports published in popula-
tions of different countries such as Saudi Arabia [8],
France [9], Kenya [10] and China [11] among others.
However in 2012, a novel betacoronavirus Middle East
Respiratory Syndrome Coronavirus (MERS-CoV) was iso-
lated in Jeddah from a patient who was suffering from
pneumonia and later died [8]. This MERS-CoV continues
to cause fatal severe lower respiratory tract illnesses in
various parts of the world, especially in the Middle East.
As of February 2015, the World Health Organization had
reported 971 laboratory confirmed cases with 356 deaths
[12]. In light of the finding of this previously unknown
coronavirus, it is probable that coronaviruses, other than
those recognized to date, may be circulating in human
populations in Kenya. As human coronaviruses are not
routinely analyzed in Kenya, this study sought to identify
and characterize HCoV strains circulating in different
parts of Kenya and thus provide a knowledge base for epi-
demiological importance of human coronaviruses.
Methods
Study sites, inclusion criteria, clinical parameters
Nasopharyngeal (NP) specimens were retrieved from ar-
chives of the respiratory virus surveillance program in
the Department of Emerging Infectious Diseases (DEID)
of the United States Army Medical Research Unit-Kenya
(USAMRU-K) [13]. These approximately 10000 archived
NP specimens were collected from a study population
comprising persons from two months of age onwards
who attended outpatient clinics in the hospitals involved
in the USAMRU-K respiratory virus surveillance; pre-
senting with influenza like illnesses symptoms. These
symptoms were: cough, sore throat, and fever (≥38 °C)
within 72 h after onset of illness. The nasoopharyngeal
swabs were suspended in virus transport medium
(VTM) and stored at −80 °C. These samples had been
screened for other respiratory viruses including influenza
viruses, HAdV, RSV, HMPV, HSV1, rhinoviruses and
non-polio enteroviruses including coxsackie viruses [14].
The surveillance network comprised Mbagathi, Isiolo,
Alupe, Kericho, Kisi, Malindi, and Port Reitz district
hospitals, as well as the New Nyanza General provincial
hospital [13]. These hospitals represent disparate geo-
graphic regions and population demographics across the
country and were delineated into Central, Northern,
Western, Highlands and Coastal regions of Kenya, respect-
ively. Inclusion criteria consisted of being an outpatient
aged at least 2 months and having influenza-like-illness
(ILI) symptoms [13]. Clinical parameters and symptoms in-
cluding recent history of ILI, cough, sore throat, difficulty
in breathing, chills, nasal stuffiness, runny nose, sputum
production, headache, joint pain, fatigue, diarrhea, vomiting
and bleeding were documented. Only those samples col-
lected from January 2009 to December 2012 for which spe-
cific consent was granted for future use were analyzed. The
minimum sample size was 173 as determined by Fischer’s
formula [15]. Based on available resources, the final number
of samples was determined by using the randomized sam-
pling technique. This involved systematic sampling, where
the first sample was picked randomly and thereafter the kth
sample selected from a list of samples for each site.
Ethical approval statement
The Walter Reed Army Institute of Research (WRAIR)
Institutional Review Board (IRB) and the Kenya Medical
Research Institute (KEMRI) Scientific and Ethics Review
Unit (SERU) reviewed and approved this work under
protocol numbers WRAIR# 2075 and KEMRI SSC#2673
respectively.
Molecular screening of the virus isolates
RNA was extracted from 140 μl of nasopharyngeal (NP)
specimens using the QIAmp Viral RNA Mini Kit (Qia-
gen, Inc.,USA) according to the manufacturer’s specifica-
tions. Viral RNA was used as a template for real time
RT-PCR using HCoV-specific primers as previously de-
scribed by Kuypers et al. [16]. For MERS-CoV detection,
samples were analysed using NCV-2012rRT-PCR assay
according to the CDC protocols. Control RNAs used
were obtained from ATCC (VR-1558D for OC43 and
VR740D for 229E) as well as NL63 RNA from the
KEMRI-Welcome Trust research program. The MERS-
CoV control RNA came along with the test kit from
CDC. Samples that tested positive by real time RT-PCR
were inoculated onto monolayers of LL-CMK2 cells
(ATCC strain CCL-7) in culture tubes (Nunc, Denmark)
to contain 100 μl of clinical specimen. The culture
medium consisted of Dulbecco’s minimum essential
medium (DMEM, Life Technologies, NY, USA) supple-
mented with 0.04 μg/ml gentamycin, 100U/mL of peni-
cillin & 100 μg/mL streptomycin (Sigma-Aldrich Co.
MO, USA). These were incubated at 33 °C under 5 %
CO2, and virus growth was monitored for cytopathic ef-
fects (CPEs) for up to 10 days. Culture controls were
obtained from ATCC and included betacoronavirus 1
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(ATCC® VR-1558™) and human coronavirus 229E
(ATCC® VR-740™).
Amplification and nucleotide sequencing of RdRp (pol)
gene
A 440 bp portion of the intergenic region of ORF1a and
ORF1b of the RNA-dependent RNA polymerase (pol)
gene of HCoVs was amplified by RT-PCR following the
method described by Woo et al. [17] . RT was performed
using the SuperScript III kit (Invitrogen, San Diego,
USA) following manufacturer’s instructions. The forward
primer was 5′-GGTTGGGACTATCCTAAGTGTGA-3′
whereas the reverse primer was 5′ -CCATCATCAGA-
TAGAATCATCATA-3′. The PCR mixture (50 μl) con-
tained RNA (300 ng), PCR buffer containing 10 mM
Tris–HCl, pH 8.3, 50 mM KCl, 3 mM MgCl2, 0.01 %
gelatin, 200 μM each of deoxynucleoside triphosphates,
and 1.0 U of Taq polymerase (Boehringer, Mannheim,
Germany). The amplification was carried out as de-
scribed by Woo et al. [17]. using the ABI 9700 auto-
mated thermal cycler (Applied Biosystems, Foster city,
USA). The PCR amplicons were purified using Exo-
nuclease I/Shrimp Alkaline Phosphatase (ExoSap-IT)
enzyme (Affymetrix, California, USA) and sequenced
directly on both strands with the same primers used in
the PCR on an automated ABI 3500XL Genetic Analyzer
(Applied Biosystems, Foster city, USA). Cycle sequen-
cing was performed using the Big Dye Terminator v3.1
sequencing kit (Applied Biosystems, Foster city, USA)
according to manufacturer’s instructions.
Sequence analysis
The nucleotide sequence fragments were edited and as-
sembled into consensus contigs using DNA baser ver-
sion 3.2 [18]. The nucleotide sequences were compared
against known sequences of coronavirus pol genes in the
GenBank database using the BLAST [19]. Prototype nu-
cleotide sequences and sequences showing highest se-
quence homologies were retrieved from GenBank for
further analyses. Multiple sequence alignment of these
was performed using Muscle v3.8 software [20]. Phylo-
genetic relationships were inferred using MrBayes soft-
ware v3.2 [21] and the tree visualized using Fig Tree
v1.4.0 software [22]. Nucleotide sequences of the partial
pol genes of the Kenyan HCoV isolates reported in this
study are available in GenBank under accession num-
bers:[GenBank: KP112147 to KP112161].
Results
A total of 417 nasopharyngeal samples were screened.
Among these, 35 tested positive for human corona-
viruses, displaying Ct values ranging from 21 to 39.
Upon molecular typing the 35 positives, 14 (37 %)
belonged to alphacoronaviruses and 21 (63 %) were
betacoronaviruses. Amongst the alphacoronaviruses, 4
were HCoV-229E and 10 were HCoV-NL63. Betacoro-
naviruses consisted of 12 HCoV-OC43 and 9 HCoV-
HKU1 species. Thus the prevalence of the various
HCoVs was 1 % for 229E, 2 % for NL63, 3 % OC43 and
2 % for HKU1.
HCoV-OC43 was detected in most months in
2009–2011, but was not detected in 2012. The peak
circulation was observed in February 2011 (Fig. 1) af-
fecting patients aged 5 months to 5 years. It was
most commonly detected in Central Kenya but never
in Northern Kenya (Fig. 2). HCoV-NL63 was detected
mostly from samples obtained in Northern and
Western Kenya and amongst patients aged 3 months
to 1.75 years (Fig. 1). HCoV-NL63 predominated from
February to June 2009, then disappeared and resur-
faced in September 2012.
HCoV-HKU1 was detected all over Kenya, but mostly
in the warmer Western and Coastal regions, with peaks
observed in June 2009, November 2010, February 2011
and December 2012 (Figs. 1 and 2). It was detected in
patients aged 4 months to 6 years. HCoV 229E was only
detected in the Western Kenya, from patients aged
9 months to 2 years with peaks detected in July and De-
cember (Fig. 2).
The range of ages of the patients in the study was be-
tween 2 months and 67 years, with a mean age of
1.5 years and median of 1.67 years. Overall, 94 % of the
HCoV were from patients aged <5 years and; 4555 % of
the patients were female and 55 % were male. All the pa-
tients from whom HCoVs were detected presented with
a cough and runny nose, with 50 % of the patients
reporting nasal stuffiness. We observed five co-
infections with a HCoV. These included two triple co-
infection involving HKU1 with influenza A (H3N2) &
human adenovirus and NL63 with influenza A (H3N2)
& human adenovirus. Three double co-infections were
observed. They included HKU1 with RSV, OC43 with
influenza A (H1N1)pdm and OC43 with influenza B
(Brisbane-like). All the co-infections, except that con-
sisting of HKU1 & RSV presented with vomiting as a
symptom. One patient with HCoV-NL63 presented
with neurological symptoms. Amongst the patients
positive for HCoV-OC43, 90 % presented with vomit-
ing and malaise.
Characterization by cell culture showed that of the 35
positive samples, 12 (34 %) produced cytopathic effects
(CPE) in cell culture after incubation for 10 days. PCR
amplification of a 440 bp fragment using CoV-specific
primers confirmed that the CPE was due to HCoVs. To
determine whether there were any HCoVs in the superna-
tants of the 23 cultures that did not yield CPE, RT-PCR
using HCoV-specific primers generated the expected
440 bp amplicon from 3 of these samples.
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Homology analyses of the partial nucleotide sequences
of the RdRp (pol) gene of the Kenyan HCoV against the
prototype strains ranged from 59 to 100 % (Table 1).
Nucleotide sequence homology within groups ranged
from 99 to 100 % for HCoV-OC43, 97–99 % for HCoV-
HKU1 and 98–99 % for HCoV-NL63. The Kenya HCoV-
229E species had 99 % nucleotide sequence identity
compared to the prototype strain.
Phylogenetic analyses of the Kenyan isolates based on
the nucleotide sequences with representative reference
strains revealed separation of the viruses into the two α
and β corona-virus groups with further resolution into
four species, corresponding to HCoV-OC43, HCoV-
NL63, HCoV-229E and HCoV-HKU1 (Fig. 3). The ma-
jority (42 %) of the Kenyan isolates clustered within the
HCoV-OC43 group, followed by HCoV-NL63 (26 %)
and HCoV-HKUI & HCoV-229E (16 % each). All the
Kenyan HCoV-OC43 isolates formed a cluster on their
own except isolate HCOV-016 which grouped with the
other HCoV-OC43 viruses from other countries across
the globe. The Kenyan HCoV-NL63 isolates clustered





















Fig. 2 Spatial Distribution of HCoVs in Kenya between 2009 and 2012. Mbagathi, Isiolo, Alupe, Kericho, Kisii, Malindi, and Port Reitz District Hospitals
are abbreviated as MBG, IDH, ALH, KCH, KSI, MDH and PDH respectively. New Nyanza General provincial hospital is abbreviated as NNY
Fig. 1 Temporal distribution of HCoVs in Kenya between 2009 to 2012
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HKU1 isolates grouped close to the French virus whose
accession number is EF507794 and the Kenyan HCoV-
229E isolates were identical to the reference strains used.
In establishing the evolution rates of the Kenyan
HCoVs, Tajima’s test showed an overall value of Tajima’s
D statistic for the eight HCoV-OC43 pol gene segments
as −1.31009 with p > 0.10 at 95 % CI. For HCoV-NL63,
the overall value of Tajima’s D statistic for the 5 se-
quences was −0.97256 with p > 0.10 at 95 % CI. The evo-
lutionary rates of the Kenyan HCoVs were also analyzed
using Fu and Li’s D as well as Fu and Li’s F tests as these
can accommodate small sample sizes. The overall Fu
and Li’s D value for the HCoV-OC43 pol gene segments
was −1.40980 and −0.97256 for HCoV-NL63, p > 0.10.
The overall Fu and Li’s F statistic was −1.51361 for
HCoV-OC43 and −0.95440 for HCoV-NL63, p > 0.10.
Discussion
HCoVs have a global distribution and are endemic to
many countries [5, 8, 23]. However, in Africa and espe-
cially sub-Saharan Africa, there is a dearth of informa-
tion about these viruses in regard to their circulation
dynamics, diversity, molecular characteristics and epi-
demiology [24].
Four out of the six known human coronavirus species
were detected by RT-PCR assay, which has been shown
to detect respiratory viruses with high sensitivity and
specificity [25]. This finding echoes previous studies in
Kenya [26] and globally where HCoVs were identified as
significant etiological agents of ILI and acute respiratory
illnesses (ARI) [9, 23]. HCoV-OC43 was the most
commonly observed HCoV and this agrees with many










































































































































































































































































































































Fig. 3 Phylogenetic relationships of partial sequences from the HCoV pol gene of the Kenyan isolates with representatives from different species.
The Kenyan HCoV sequences are in blue color, the prototype strains are in red and representative strains in black; each sequence is represented
by the GenBank accession number. The PEDV in green was used as an out-group. The tree was constructed by Mr. Bayes v3.2, using the general
time-reversible nucleotide substitution model. Posterior probability support values are shown as percentages at the nodes
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predominance [27]. HCoV-NL63 contributed to 2 % of
ILI cases in our study period. This finding echoes the
findings in South Africa by Smuts, [28] where they
showed that HCoV-NL63, contributed to 2.4 % of ILI
cases in the period of one and a half years. HCoV-
229E contributed to 1 % of ILI cases in the study
period, echoing results from other studies worldwide
that show low detection of this HCoV [27]. This is
comparable to what has been observed globally,
where HCoV activity is sporadic throughout the year
with no obvious distinct seasonality [29]. Overall, the
symptoms associated with coronavirus infection were
similar to what has been reported elsewhere [1, 7,
24] and it was difficult to distinguish an infection in-
volving HCoV using symptoms alone. This justifies
the WHO classification of respiratory viral infections
into influenza-like-illnesses without clear distinction
of a specific respiratory virus infection based on
symptoms alone.
Out of 35 PCR-positive cases for HCoV, only 12
(34 %) yielded virus in LLCMK2 [30] and were con-
firmed by PCR. This was expected because molecular
assays including PCR are more sensitive and specific at
detecting pathogens [31, 32] than cell culture or ser-
ology. The low isolation rate may be attributed to low
viral loads in the patients or the presence of inactivated
viruses, potentially due to poor specimen handling and/
or storage. Nonetheless, this finding agrees with reports
of poor growth and a lack of cytopathic effect in cell cul-
tures by HCoVs [33].
Phylogenetic analysis confirmed that the Kenyan isolates
belonged to the alpha and betacoronavirus groups [6].
The Kenyan isolates clustered together with reference
strains indicating that the Kenyan HCoVs are strain
variants of those circulating elsewhere. Natural selection
analyses revealed that the Kenyan HCoV-OC43 and
HCoV-NL63 viruses were under negative selection, albeit
not statistically significantly so. We did not detect any
MERS-CoV or SARS-CoV.
This study had several shortcomings. The small
sample size made it difficult to analyze evolutionary
rates using the robust SLAC and FEL methods. Only
a portion of the virus genome was analyzed and the
evolution rates based on this small portion of the
genome may be misleading. These shortcomings not-
withstanding, it was demonstrated that four HCoV
subtype strains were in circulation in Kenya from
2009 to 2012 and were similar to those circulating in
other countries. However, sustained respiratory virus
surveillance is necessary to monitor introductions of
any of these dangerous species. Furthermore, full gen-
ome studies are required to provide comprehensive
insight into the genetics and evolutionary characteris-
tics of HCoVs in Kenya.
Conclusions
There were yearly variations in the prevalence and circu-
lation patterns of individual HCoVs in Kenya. This paper
reports on the first molecular characterization of human
Coronaviruses in Kenya, which play an important role in
causing acute respiratory infections among children.
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